BioSpace News Archive

Transparency Market Research has published a new report on the global hemostasis valves market for the forecast period of 2019–2027. According to the report, the global hemostasis valves market was valued at ~US$ 135 Mn in 2018, and is projected to expand at a CAGR of 4.5% from 2019 to 2027.

The industry analysis report is considered a valuable source of information about the global Blood Bags industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

Increasing geriatric population, rising demand for safety syringes, and increasing demand for disposable syringes amidst the ongoing coronavirus pandemic are key factors fueling global market growth.

As the Omicron variant spreads rapidly, 3M has been providing information about 3M N95 respirators – where to buy them, how to ensure a proper fit, and why they are considered the standard for protection.

Today, the Center for Contemporary Sciences (CCS) and BICO formalized a strategic partnership aiming at modernizing drug development and replacing animal testing with more human-relevant methods.

KromaTiD is excited to announce early access to our KromaTiD Pinpoint FISH TP53/CEP17 Kit, our new product designed to supply the highest resolution, lowest background, and lowest limit of detection available.

Rise in prevalence of target chronic diseases like cancer, increase in unhealthy lifestyle habits, mergers and acquisitions by major companies, product launches, the development of biologics with higher efficiency and favorable research funding scenario are key factors contributing to high CAGR of Biologics during forecast period.

Rising awareness about in vitro diagnostic techniques and growing R&D investments and initiatives is driving product demand and use, and in turn driving market growth.

OraSure Technologies, Inc., a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced that its InteliSwab® COVID-19 rapid tests detect the Omicron variant as effectively as they detect the original SARS-CoV-2 strain and other previous variants of concern, including Delta, Alpha, Beta and Gamma.

The Company thanks Mr. Schwartz for his valuable contributions and wishes him every success in his future endeavors.